Literature DB >> 17277784

Structural basis for viral late-domain binding to Alix.

Sangho Lee1, Anjali Joshi, Kunio Nagashima, Eric O Freed, James H Hurley.   

Abstract

The modular protein Alix is a central node in endosomal-lysosomal trafficking and the budding of human immunodeficiency virus (HIV)-1. The Gag p6 protein of HIV-1 contains a LYPx(n)LxxL motif that is required for Alix-mediated budding and binds a region of Alix spanning residues 360-702. The structure of this fragment of Alix has the shape of the letter 'V' and is termed the V domain. The V domain has a topologically complex arrangement of 11 alpha-helices, with connecting loops that cross three times between the two arms of the V. The conserved residue Phe676 is at the center of a large hydrophobic pocket and is crucial for binding to a peptide model of HIV-1 p6. Overexpression of the V domain inhibits HIV-1 release from cells. This inhibition of release is reversed by mutations that block binding of the Alix V domain to p6.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277784      PMCID: PMC2377018          DOI: 10.1038/nsmb1203

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  44 in total

1.  HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.

Authors:  J Martin-Serrano; T Zang; P D Bieniasz
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

2.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

3.  An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains.

Authors:  Utpal M Munshi; Jaewon Kim; Kunio Nagashima; James H Hurley; Eric O Freed
Journal:  J Biol Chem       Date:  2006-12-08       Impact factor: 5.157

4.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

Authors:  M D Winn; M N Isupov; G N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-01

5.  Involvement of the conserved adaptor protein Alix in actin cytoskeleton assembly.

Authors:  Shujuan Pan; Ruoning Wang; Xi Zhou; Guangan He; John Koomen; Ryuji Kobayashi; Le Sun; Joe Corvera; Gary E Gallick; Jian Kuang
Journal:  J Biol Chem       Date:  2006-09-10       Impact factor: 5.157

6.  Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells.

Authors:  A Kikonyogo; F Bouamr; M L Vana; Y Xiang; A Aiyar; C Carter; J Leis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

7.  The glioma-associated protein SETA interacts with AIP1/Alix and ALG-2 and modulates apoptosis in astrocytes.

Authors:  B Chen; S C Borinstein; J Gillis; V W Sykes; O Bogler
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

8.  Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).

Authors:  L VerPlank; F Bouamr; T J LaGrassa; B Agresta; A Kikonyogo; J Leis; C A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

9.  A role for ubiquitin ligase recruitment in retrovirus release.

Authors:  B Strack; A Calistri; M A Accola; G Palu; H G Gottlinger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

10.  Maximum-likelihood density modification.

Authors:  T C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-08
View more
  87 in total

1.  Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.

Authors:  Maria Francesca Baietti; Zhe Zhang; Eva Mortier; Aurélie Melchior; Gisèle Degeest; Annelies Geeraerts; Ylva Ivarsson; Fabienne Depoortere; Christien Coomans; Elke Vermeiren; Pascale Zimmermann; Guido David
Journal:  Nat Cell Biol       Date:  2012-06-03       Impact factor: 28.824

2.  Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins.

Authors:  Xi Zhou; Jiali Si; Joe Corvera; Gary E Gallick; Jian Kuang
Journal:  Biochem J       Date:  2010-12-15       Impact factor: 3.857

Review 3.  Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation.

Authors:  Xuefeng Ren; James H Hurley
Journal:  Traffic       Date:  2011-05-13       Impact factor: 6.215

Review 4.  Dynamics of ESCRT proteins.

Authors:  Nolwenn Jouvenet
Journal:  Cell Mol Life Sci       Date:  2012-06-06       Impact factor: 9.261

Review 5.  The ESCRT complexes.

Authors:  James H Hurley
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-07-23       Impact factor: 8.250

6.  Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1.

Authors:  Qianting Zhai; Michael B Landesman; Howard Robinson; Wesley I Sundquist; Christopher P Hill
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

7.  Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix).

Authors:  Xiaoli Shi; Stephane Betzi; Adrien Lugari; Sandrine Opi; Audrey Restouin; Isabelle Parrot; Jean Martinez; Pascale Zimmermann; Patrick Lecine; Mingdong Huang; Stefan T Arold; Yves Collette; Xavier Morelli
Journal:  FEBS Lett       Date:  2012-05-26       Impact factor: 4.124

8.  Alternative polyadenylation produces two major transcripts of Alix.

Authors:  Zhehui Feng; Chuan Fen Wu; Xi Zhou; Jian Kuang
Journal:  Arch Biochem Biophys       Date:  2007-07-01       Impact factor: 4.013

Review 9.  Viral membrane scission.

Authors:  Jeremy S Rossman; Robert A Lamb
Journal:  Annu Rev Cell Dev Biol       Date:  2013-05-31       Impact factor: 13.827

10.  Functional replacement of a retroviral late domain by ubiquitin fusion.

Authors:  Anjali Joshi; Utpal Munshi; Sherimay D Ablan; Kunio Nagashima; Eric O Freed
Journal:  Traffic       Date:  2008-08-09       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.